SearcharxivSearch

arXiv subjects

Camile Bahi

Publications and source records attributed to Camile Bahi.

2 recordsLinked to original sources

5-HT2A mediated plasticity as a target in major depression: a narrative review connecting the dots from neurobiology to cognition and psychology

As the world's first primary morbidity factor, depression has a considerable impact on both an individual as well as a societal level. despite their discovery several decades ago, classical antidepressants have been shown to provide limited benefits against this condition. However, substances such as ketamine and psychedelics have recently shown promising results and even received the grade of Breakthrough therapy for this indication. The accurate mechanisms of action underlying the efficacy of these substances are still to be defined, but some similarities appear to be shared on different levels across these substances. These include their structural, functional and behavioral plasticity promoting abilities, as well as their capacity to promote Brain-Derived Neurotrophic Factor overexpression, which seems to constitute a key element underlying their immediate and long-lasting action. From this observation, the present review aims to examine and connect the pharmacological pathways involved in these therapies to the neurobiological, cognitive and psychological responses that could be shared by both 5-HT2AR agonists and NMDA antagonists. It is suggested that BDNF overexpression resulting from mTOR activation mediates both structural and functional plasticity, resulting in connectivity changes among high-level cognitive networks such as the Default Mode Network, finally leading to an increased and long-lasting psychological flexibility. Connecting these pieces of evidence could provide insights about their precise mechanisms of action and help researchers to develop biomarkers for antidepressant response. If the hypotheses suggested in this review are verified by further trials, they could also constitute a starting point to developing safer and more efficient antidepressants, as well as provide information about the interactions that exist between different neurotransmitters systems.

q-bio.QM

Psilocybin based therapy for cancer related distress, a systematic review and meta analysis

Background : depression and anxiety are common in patients with cancer, classical antidepressant has no proven efficacy on this type of distress compared to placebo. A Psilocybin (serotoninergic hallucinogen) based therapy appear to give promising results among recent studies. Aims : to examine if a Psilocybin based therapy could be considered for patients with cancer related depression and anxiety and to assume it's safety. To sum up Heffter institute work, as the main institute working on this topic. Method : following PRISMA (Preferred Reporting Items for Systematic reviews and Meta Analyses) guidelines, a systematic review was conducted, for quantitative and qualitative studies about psilocybin for treating cancer related depression and anxiety. Pubmed and the Heffter institute databases have been reached for this purpose, separating studies in types : qualitative or quantitative. We studied the effects on cancer related depression and anxiety separately and investigated the psychological and neurobiological mechanisms. Results : the four studies included a total of 105 randomized patients, meta analysis on depression and anxiety with pooled Peto odds ratio showed a significant superiority of Psilocybin over placebo. The substance appeared to be safe for this type of patients. Surprising psychological mechanisms hypothesis have been found out. Conclusion : psilocybin appear to be potentially useful as a treatment for cancer related depression and anxiety. Future research should verify these findings on wider population and eventually seek a way to apply therapy to non hospitalized (ambulatory) patients. Keywords : psilocybin, depression, anxiety, review, meta-analysis

q-bio.QM